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The thymus is a primary lymphoid organ, essential for T cell maturation and selection. There
has been long-standing interest in processes underpinning thymus generation and the
potential to manipulate it clinically, because alterations of thymus development or function
can result in severe immunodeficiency and autoimmunity. Here, we identify epithelial-
mesenchymal hybrid cells, capable of long-term expansion in vitro, and able to reconstitute
an anatomic phenocopy of the native thymus, when combined with thymic interstitial cells
and a natural decellularised extracellular matrix (ECM) obtained by whole thymus perfusion.
This anatomical human thymus reconstruction is functional, as judged by its capacity to
support mature T cell development in vivo after transplantation into humanised immuno-
deficient mice. These findings establish a basis for dissecting the cellular and molecular
crosstalk between stroma, ECM and thymocytes, and offer practical prospects for treating
congenital and acquired immunological diseases.
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The thymus is a primary lymphoid organ where haemato-poietic progenitors are instructed to become functionalT cells. It undergoes postnatal involution, but remains in
place throughout life1,2. The epithelial component of the thymus
stroma derives from the endoderm, whereas mesenchymal stroma
derives from the neural crest and in part from incoming ves-
sels3,4. Reflecting their fundamental role in immune regulation,
many studies have provided insight into the origins and pheno-
typic complexity of thymic epithelial cells (TEC)5 and the
molecules that mediate their activities6–10, including AIRE and
MHC Class II (MHCII) that are required for selecting T cells of
diverse, non-autoaggressive specificities5,11.
A transcriptomic analysis describing human thymic complexity at
the single-cell level was recently reported12. A core, long-established
discriminator of TEC is their assignment as either cortical (cTEC) or
medullary (mTEC), reflecting the anatomical regions to which the
differentiated TEC contribute. However, while defined TEC and
other stromal cell types have been studied in considerable detail,
there is only incomplete molecular and cellular detail about how
TEC and other cells collectively contribute to the complex three-
dimensional (3D) organisation of the human thymus.
Since the thymus controls the development of both immune
competence and tolerance, its functional dissection and sub-
sequent reconstruction with desired cell populations might pro-
vide powerful tools applicable to many medical conditions,
including primary or acquired immune deficiencies. Indeed, such
is the clinical unmet need that cultivated thymus slices are cur-
rently used for transplantation into athymic patients. Moreover,
thymic therapeutic strategies might likewise be applicable to
organ transplantation in which tolerance is a key obstacle to long-
term graft acceptance.
This notwithstanding, attempts to rebuild a fully functional
thymus have so far met with limited success13–15, possibly because
of the organ’s inherent complexity. Moreover, there remains some
uncertainty over the nature of postnatal epithelial stem/progenitor
and mesenchymal cells including the capacity for extensive
expansion ex vivo that would seem crucial to this aim16–18. In this
regard, we previously identified clonogenic multipotent stem cells
in the rodent thymus able of contributing to the skin and thymic
microenvironment after extensive ex vivo expansion19.
Our current study demonstrates that long-term expanding
epithelial cells are present in the human thymus, and display an
hitherto unprecedented hybrid epithelial–mesenchymal pheno-
type. These clonogenic cells could repopulate whole-organ scaf-
folds, phenocopying the unique 3D epithelial network of the
thymus. Such reconstituted scaffolds established a functional
microenvironment supporting human T cell development from
lymphoid progenitors in vitro and haematopoietic stem cells
(HSC) in vivo. Thus, by overcoming obstacles to constructing a
functional thymus with only expanded, postnatal donor stromal
cells, our findings offer practical prospects for treating immune
disorders including congenital athymia for which current thera-
pies are limited20.
Results
Long-term in vitro expansion identifies clonogenic TEC. As a
first experimental goal we attempted to isolate from human
thymus stromal cells with clonogenic potential. Human thymi
were obtained from 33 patients ranging in age from 3 days to 11
years who underwent open-chest cardiac surgery. Thymus tissues
were enzymatically dissociated to single-cell suspension and
plated over a lethally irradiated feeder layer for the derivation of
thymic epithelial cells (TEC). All thymi, independent of donor
age, contained clonogenic TEC generating colonies that could be
expanded extensively upon weekly passage (Fig. 1a).
Subsequently, we aimed at defining if these clonogenic TEC
derive from the cortex and/or medulla. To this end, we adopted a
cell-sorting strategy to dissect and prospectively isolate thymic
stromal compartments including the epithelium (cortex and
medulla TEC) and the interstitium (TIC). After a few cycles of
enrichment, the CD45− stromal population went from 0.02–2%
(freshly dissociated tissue) to ~40–80% (Supplementary Fig. 1a),
allowing subsequent sorting on the basis of additional surface
markers. We used EpCAM and CD205 expression levels21,22 to
separate EpCAMhighCD205− medullary TEC (mTEC) from
EpCAMlowCD205+ cortical TEC (cTEC; Fig. 1b). Unexpectedly,
the mesenchymal marker CD90 (THY1) was also expressed by a
large proportion (>60%) of mTEC and approximately all cTEC,
as well as by TIC (Fig. 1c). CD49f, the α6-integrin which
contributes to hemidesmosomes and is expressed by cells at the
basal layer of stratified epithelia23,24, was differentially expressed
in both mTEC and cTEC populations (Fig. 1d), providing a basis
to sort for CD49f+ mTEC or cTEC (“Type1”), and CD49f−
mTEC or cTEC (“Type2”) subpopulations.
In support of our sorting strategy, we employed RT-qPCR to
assess expression of established functional markers of freshly
isolated medullary (e.g. AIRE1) and cortical (e.g. β−5T, CD205)
epithelial cells, respectively (Supplementary Fig. 1b). We noted
differential expression in cortical versus medullary cells of
cytokines and key transcription factors for thymus specification
and/or thymopoiesis25 such as FOXN1 and PAX1 whereas
Vimentin (VIM) was comparably expressed by all sorted
populations examined (Supplementary Fig. 1c).
To assess the colony-forming potential of freshly isolated
Type1 and Type2 human cTEC and mTEC, we plated them over
lethally irradiated feeders, as described above. The colony-
forming efficiency (CFE) assay consistently revealed that the
highest clonogenicity resided in Type1 mTEC (CFE 2–4%) and
Type1 cTEC (1–2%), while Type2 mTEC had a very low CFE
(0.1–0.2%) and Type2 cTEC did not give rise to any expanding
colonies (Fig. 1e). Entirely consistent with their greater
clonogenicity, Type1 mTEC and Type1 cTEC were the only
epithelial subpopulations that could be expanded over serial
passages. Type1 cTEC, although being less abundant than their
medulla counterparts, robustly expanded in culture and could
reach comparable numbers to Type1 mTEC (Fig. 1f and
Supplementary Fig. 1d).
In order to define the transcriptional profile of thymic
clonogenic cells, we performed genome-wide RNA sequencing
of cultivated Type1 mTEC, Type1 cTEC and also of TEC derived
in culture without any sorting strategy. Expression of genes such
as SIX1, EYA1, HOXA3, PAX1 and PAX9 detected by RNA
sequencing of cultured TEC, confirmed that clonogenic TEC
maintained thymic identity independently of their compartment
of origin (cortical or medullary). Both cortical (CSTV, KNICP3,
CD274) and medullary (CDH1, EpCAM, CD24) genes were
retained by cultured cells (Fig. 1g). When analysed by RT-qPCR
for transcription factors with documented importance for thymic
epithelial cells, both mTEC and cTEC clonogenic cells expressed
comparable levels of RNAs encoding TP63, FOXN1 and signalling
molecules such as SCF (Supplementary Fig. 1e). Indeed, mTEC
and cTEC showed only 11 differentially expressed genes out of
14,347 (0.08%) thus confirming that in culture they display a
common phenotype (Supplementary Fig. 2a, b). Thus, in
subsequent experiments, we refer to “clonogenic TEC” whether
or not they originate from medullary or cortical zones.
Single-cell RNA sequencing defines cell clusters common to
medullary and cortical populations in vivo. With the intention
of using clonogenic cells expanded in vitro for thymus
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reconstitution, we first wanted to contextualise the cells’ profiles
relative to freshly isolated mTEC and cTEC, directly ex vivo.
Thus, freshly isolated subpopulations of mTEC and cTEC, Type1
and Type2, were subjected to single-cell RNA sequencing
(scRNA-seq), placing them into the broader context of other
murine and human scRNA-seq studies12,26–30. This combined
approach offered the opportunity for high resolution profiling of
freshly isolated thymic epithelial cells enriched for
clonogenic cells.
When the mTEC and cTEC subpopulations were presented in
a single UMAP (Fig. 2a), we were able to annotate main cell
subgroups among sorted epithelial cells, defining 15 cell clusters
distinguishable on the basis of shared common features: cTEC
grouped within three main clusters, while mTEC grouped within
five, in addition to which we identified four TEC clusters
common to both cortex and medulla (“comTEC”; Fig. 2b). Note
that the remaining three clusters (residual cells) represented
polymorphonuclear, dendritic cell and thymocyte contaminants
from the single-cell sorting (Fig. 2b). These main cell subgroups
were validated by specific gene signatures of cTEC, mTEC or
comTEC visualised in category view feature plots (Fig. 2c).
Examples of single gene patterns of expression for each category
(cTEC, mTEC and comTEC) are shown in Supplementary
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Provocatively, the comTEC clusters included cells characterised
by an epithelial–mesenchymal transition (EMT) signature (cluster
12), proliferation markers (cluster 13) and poly-keratin-
expressing cells (cluster 14), while cluster 15 displayed a
distinctive signature enriched in ion transporters31 (Fig. 2c).
When we compared the transcriptional signatures of comTEC
and of specific mTEC and cTEC clusters to the transcriptional
profile of clonogenic TEC in vitro, it was evident that the latter
expressed transcriptional signatures present in comTEC (pro-
liferation, EMT and polykeratins) but not in other clusters of
freshly isolated mTEC or cTEC (Fig. 2d).
TEC co-express epithelial and mesenchymal markers but are
distinct from thymic interstitial cells. Based on the striking co-
expression of CD90 (THY1) with EpCAM observed by FACS
(Fig. 1c) and also by the detection of an EMT signature in the
comTEC cluster of freshly isolated TEC (Supplementary 2f), we
further investigated the possibility that human thymic epithelial
cells might be characterised by a distinctive
epithelial–mesenchymal hybrid phenotype. To this end, we per-
formed immunohistochemistry analysis on postnatal thymi of
our donors and clearly detected cells consistently co-expressing
cytokeratins (CK) with mesenchymal markers such as CD90,
vimentin (VIM) and to a less extent, the mesoderm marker TE7
(Fig. 3a), thus confirming at the protein level a hybrid phenotype
expressed within healthy thymus tissue.
In culture, clonogenic TEC were CD49f+, in active cell cycle
(MKI67+) and double positive for CK5-14 and CK8-18. In
contrast to all epithelia described in culture so far, but in line with
what reported above, clonogenic TEC stably co-expressed
mesenchymal markers such as CD90, VIM and TE7 (Fig. 3b).
In addition, some TEC expressing TP63, a transcription factor of
the basal layer of stratified epithelia and a master regulator of
thymic epithelial cells32, were also positive for VIM in vitro and
in vivo (Fig. 3a, b). Genome-wide transcriptomic analysis of
cultured TEC confirmed the expression in vitro of the EMT
signature defined by scRNA sequencing (Supplementary Fig. 2g).
Strikingly, expression of mesenchymal markers also correlated
with high motility and migration that are typical of mesenchymal
cells, as demonstrated by live-imaging of a TEC colony over
4 days in culture (Supplementary Movie 1). Thus, the hybrid
epithelial–mesenchymal phenotype of epithelial cells appeared to
be a highly distinctive feature of the thymus in vivo and ex vivo.
In addition to TEC, we also expanded CD90+EpCAM−
interstitial cells (Fig. 1c [TIC]). These cells did not grow under
culture conditions designed for epithelial cells, but proliferated
extensively for many passages in mesoderm culture conditions33,
thus allowing us to obtain billions of cells in only a few weeks
(Fig. 3c). Immunofluorescence showed expression of mesenchy-
mal markers such as TE7, VIM, PDGFRβ, Chondroitin Sulfate
Proteoglycan 4 (NG2) and Smooth Muscle Actin (αSMA; Fig. 3d).
FACS analysis revealed that these TIC consistently expressed
PDGFRα, PDGFRβ, CD90, CD146, and, to variable extents, NG2
and alkaline phosphatase (ALP), consistent with a perivascular
phenotype34 (Fig. 3e and Supplementary Fig. 3a). FACS analysis
of expanding TIC showed no presence of either epithelial
(CD49f+) or immune (hCD45+) cells (Supplementary Fig. 3b).
Finally, we compared the transcriptional profile of the cultured
epithelial clonogenic cells and thymic interstitial cells from
paediatric samples of different age by genome-wide RNA
sequencing. As expected, cultivated TEC appeared clearly distinct
from the TIC as illustrated by the principal component analysis
(PCA1; Supplementary Fig. 3c). Nevertheless, the data confirmed
that the two cell types also share an exquisite similarity in the
expression of genes related to EMT, including highly expressed
COL1A1, MMP2, TGFBR2 and FN1 (Supplementary Fig. 3d).
Natural thymic scaffolds. Given the capacity of TEC and TIC to
expand substantially under the culture conditions employed, it
became possible to obtain billions of TEC and TIC within a
relatively short time-period, establishing them as putative stem/
progenitor cells with clinical applicability. In order to assess their
capacity to functionally differentiate we developed a unique
approach to obtain thymic extracellular matrix (ECM) by whole-
organ decellularisation that would provide a 3D structure for
seeding thymic stroma and guide cellular re-organisation
according to a physiological pattern.
The thymus develops from the third pharyngeal pouch4 as
separate lobes which migrate into their final location as
independent vascularised structures, after which the lobes adhere
to each other through a layer of connective tissue. Owing to the
lack of a main arterial supply to the whole-organ, it has not
hitherto been possible to apply a perfusion-decellularisation
approach to obtain ECM scaffold from the thymus, analogous to
that achieved for many other organs35. Thus, we developed de
novo an approach permitting whole-organ perfusion of the
thymus. Briefly, one carotid artery was left open for subsequent
cannulation to allow perfusion of the organ, while all other
arteries (downstream of the emergence of vessels reaching the
thymus) were closed, as shown by gross microscopy and as
detailed in Methods section (Fig. 4a, upper panels).
We applied X-ray microfocus-computed tomography (Micro-
CT) of cannulated whole rat thymi to allow 3D visualisation of
the 24G cannula sited in the carotid artery (Fig. 4b). Micro-CT is
Fig. 1 Prospective isolation of thymic epithelial (TEC) and interstitial cells (TIC). a Left panel: Rhodamine-B staining of TEC: 500 cultured TEC were
seeded in a dish for colony-forming efficiency (CFE); the dish was stained after 12 days of culture. TEC gave rise to colonies of variable sizes that stained
differently with Rhodamine. Scale bar, 2 cm. Right panel: growth curve over serial weekly passaging of TEC (X axis, number of weekly passages; Y axis,
cumulative cell number); significance, mean ± SD (n= 3; donor age from 2 months to 4 years). b Left panel: immunofluorescence labelling of thymic
epithelial cells in human post-natal thymus where anti-CD205 antibody (green) marked cortical TEC (cTEC) and anti-CK5-14 (red) marked medullary TEC
(mTEC). Scale bar, 50 μm. Right panel: FACS plot visualising cTEC (EpCAMlowCD205+, 4.87%), mTEC (EpCAMhighCD205−, 11.1%) and TIC
(EpCAM−CD205−, 61.5%) in the CD45-negative population enriched for sorting (n= 18; age from 3 days to 6 years). Representative analysis, thymus
donor age 4 months (live cells= 51600). c FACS plots showing CD90 expression in enriched EpCAMhigh mTEC (red), EpCAMlow cTEC (green) and
EpCAM− TIC (blue) respectively. Gating was decided on negative unstained control value for each channel. Same thymus as in 1b. d Representative FACS
analysis for CD49f and CD90 demonstrating CD49f+ (Type1) and CD49f− (Type2) populations. Same thymus as in 1b and 1c. e Rhodamine-stained
indicator dishes of sorted cTEC and mTEC subtypes (4000 events/dish) cultivated for 12 days, colony-forming efficiency (CFE). mTECType1 is the most
clonogenic population (2–4%) and cTECType1 (1–2%) is the clonogenic population of the cortex (n= 4). f Growth curve over serial weekly passaging of
sorted mTECType1 and cTECType1 (X axis, number of weekly passages; Y axis, cumulative cell number; n= 4 independent cultures; data are presented as
mean value ± SE; donor age from 2 months to 4 years old). g Gene expression signature of cultivated clonogenic TEC (unsorted, black), medullary (Type1
mTEC, red) and cortical TEC (Type1 cTEC, green). Heatmap and hierarchical clustering of samples according to expression of thymic identity genes (SIX1,
EYA1, PAX1 and PAX9), markers of thymic cortex (CTSV, PRSS16 and LY75) and medulla (CD24 and CDH1).
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a non-destructive technique that permits visualisation of the
vasculature containing blood (white, dense areas) via iodine
contrast; moreover, it facilitated clear demarcation of cortical
(brighter areas, C) and medullary regions (M) through virtual
segmentation, thereby demonstrating whole-organ 3D imaging
of the thymus at high resolution (Fig. 4b; Supplementary Fig. 4a
and Supplementary Movie 2). When the parenchyma was
rendered more transparent, the 3D whole-organ micro-CT
images allowed enhancement of the 3D thymic vascularisation
segmented in red (Fig. 4c). Standard histology by masson
trichrome (MT) and haematoxylin & eosin (H&E) stains
confirmed the distribution of cortical and medullary areas and
vascular (*) structures (Fig. 4d, e).
Importantly, we demonstrated that this microsurgical approach
allowed perfusion of both thymic lobes by injecting a Microfil®
compound through a single cannula, and, after solidification and
fixation, we imaged the whole organ by Micro-CT (Fig. 4f, g).
Perfusion through the cannula of MilliQ-H2O, followed by
detergent and DNAse solutions allowed whole-organ decellular-
isation over a 6-day period (Fig. 4a, lower panels). MT and
H&E stains demonstrated complete acellularity of the organ,
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preservation of the macro- and micro-vasculature (Fig. 4h, i and
Supplementary Fig. 4b, c). Thymic ECM was characterised by
colorimetric staining for ECM proteins that demonstrated
preservation of elastin while confirming the absence of inter-
mediate filaments, including keratins (Supplementary Fig. 4d).
Likewise, there was essentially no residual DNA after decellular-
isation (Supplementary Fig. 4e). Scanning electron microscopy
(SEM) showed distribution of ECM fibres at high resolution
(Supplementary Fig. 4f), and this was preserved in whole-organ
scaffolds which were sterilised by γ-radiation and which could be
stored in physiologic solution.
Natural scaffolds facilitate functional thymic morphogenesis
ex vivo. We next investigated the capacity of epithelial thymic
cells extensively expanded as described above to repopulate and
grow within a whole-organ 3D natural scaffold ex vivo. Scaffolds
were injected with 4–6 million clonogenic TEC that had been
expanded for 4–6 weeks. Repopulated scaffolds were then
maintained in static conditions for up to 14 days in epithelial
medium, over which time they showed scaffold remodelling and
progressively increasing volumes (Fig. 5a). TEC re-organised
along the 3D ECM structure from the subcapsular areas
(CD49fhigh) into the innermost regions of the scaffold. Seeded
TEC expressed CK5-14+ and/or CK8+; were in active cell cycle
(MKI67+); were negative for the apoptotic marker, Caspase 3;
and broadly expressed TP63 (Fig. 5b and Supplementary Fig. 5a).
These data demonstrate that TEC were supported by the 3D
ECM. Nevertheless, under these in vitro conditions and in the
absence of any other cell type (Fig. 5c), seeded cells resem-
bled TEC detected in patients affected by primary immunodefi-
ciencies wherein the distribution of thymic stroma is severely
perturbed36.
To address this issue, we next co-seeded expanded TEC
together with cultured TIC. We optimised the TEC: TIC ratio at
5:1 in order to avoid interstitial cell overgrowth. Strikingly, after
only 5 days of co-culture, the presence of TIC promoted a
cordoned stromal organisation that largely phenocopied an early
(9-week post-conception, wpc) foetal thymus (Fig. 5d, e). TIC
were found to be crucial for re-organisation of TEC along the 3D
ECM of the reconstituted scaffold. In the presence of TIC, cortical
CK8+ TEC were mostly surrounded by a subcapsular-like layer of
CK5-14+ TEC that expressed CD49f and TP63, phenocopying
the native thymus (Fig. 5f and Supplementary Fig. 5b, c). SEM
of repopulated scaffolds confirmed cell–cell and cell–matrix
interactions between TEC, TIC and decellularised ECM, as well as
the preservation of vascular structures (*) (Supplementary
Fig. 5d).
We next considered it appropriate to compare the organised
thymus stroma reconstituted in vitro from clonogenic cells with
clinical thymus slices that are cultured on a sponge up to 21 days,
in order to remove donor thymocytes, before transplantation into
athymic patients20,37. The healthy status of the reconstituted
stroma within our scaffolds seemed of particular relevance when
considering that current clinical protocols for thymus slice
preparation show disorganised stroma with variable survival
after 14 and 21 days of culture, and equally importantly, residual
CD3+ thymocytes that pose an overt risk of graft-versus-host
disease for a transplant recipient (Supplementary Fig. 5e).
In order to assess the functional potential of the 3D thymic
microenvironment, natural scaffolds were repopulated with TEC
and TIC as described, and cultivated for 4–6 days before being
injected with thymocyte precursors. Given the size (0.5–1 cm3) of
the repopulated scaffolds, we cultured cells for a relatively short-
term (up to 2 weeks) insufficient time vis-a-vis 5–6 weeks
required for haematopoietic stem cell (HSC) lineage differentia-
tion38. To accommodate this, scaffolds were repopulated with
flow cytometry-sorted triple negative thymocytes (TN,
CD3−CD4−CD8−) characterised for the expression of early
lymphoid markers CD1a, CD5, CD7 and CD31 (Supplementary
Fig. 5f, g). Immune cells within repopulated scaffolds were
negative for CD33, positive for CD1a and could differentiate
toward both double (DP) and mature single positive (SP) CD4+
and CD8+ stages, resulting in a ratio of CD4+:CD8+ cells that
phenocopies the ratio found in the native human thymus
(Fig. 5h). EpCAM+ TEC within the scaffolds expressed also
HLA-DR which was not detected on TEC expanding in culture
(Supplementary Fig. 6a–c). In contrast, TN injected into scaffolds
containing TIC-only stroma did not survive (Supplementary
Fig. 6d). In conclusion, it was possible to cultivate organ-size, 3D
structures that supported the survival and appropriate spatial
organisation of thymic stromal cells, that in turn facilitated
thymocyte differentiation.
Human thymus morphogenesis recapitulated in vivo. We next
investigated whether repopulated thymus scaffolds might mature
and sustain human T cell reconstitution from HSC in vivo. To
this end, scaffolds that had been repopulated and cultured in vitro
for 5–6 days, were implanted subcutaneously into humanised
NOD.scid.Il2Rγcnull (NSG) mice. NSG mice were sub-lethally
irradiated and transplanted with highly purified CD34+ HSC
from either human cord blood (CB CD34+) or foetal liver (FL
CD34+) 4–6 weeks before they were implanted with thymus
scaffolds co-seeded with stromal cells (TEC and TIC) and CD34+
HSC at defined ratios (Supplementary Fig. 7a). Note that the
HSC, which can act as sources of human myeloid cells, were
added to the grafts to accelerate thymus development, but were
not essential (see below).
Decellularised natural scaffolds previously seeded and culti-
vated in vitro, were grafted subcutaneously into NSG mice. At
least two scaffolds were grafted into each mouse. Grafts were
Fig. 2 Single-cell RNA sequencing of freshly isolated TEC defines common cell clusters to mTEC and cTEC that are maintained in vitro. a UMAP
visualisation of the cellular composition of the human post-natal thymus by clusters indicated by colours and numbers from 1 to 15 describing the
heterogeneity of cTEC (1–3) and mTEC (7-11). Clusters 12–15 were common to cortex and medulla (comTEC); clusters 4–6 described residual immune cells
(PMNs, DCs and thymocytes). b UMAP representation of the same thymic cells indicating main subgroups (cTEC, cortical epithelial cells, in green; mTEC,
medullary epithelial cells, in red; TEC cells with common features, in brown and residuals of immune cells in grey). c Area under the curve (AUC) summary
intensity plots for the gene signatures of cTEC (CCL25, CD274, CFC1, CTSV, FOXN1, KCNIP3, LY75, PRSS16, PSMB11, SCX, SLC46A2, TBATA and TP53AIP1),
mTEC (CD24, CDH1, CLDN3, EPCAM and HES6) and comTEC (CCL19, CFTR, COL1A1, DAB2, FN1, GLIPR2, HAS2, HGF, KRT14, KRT15, LOXL2, MKI67, MMP2,
S100A4, SNAI1, SNAI2, TFCP2L1, TGFB3, TGFBR2, THY1, TP63, TWIST1 and ZEB1) clusters showing expression level for lineage specific genes in a purple scale.
Single-cell expression values are represented as calculated median intensity of area under the curve. d Heatmap and hierarchical clustering of cultured
cTECType1 (green, n= 3), mTECType1 (red, n= 3) and cultured unsorted TEC (black, n= 2) according to main genes clusters defined in single-cell RNA
sequencing. Genes list is displayed on the right and includes comTEC signatures (epithelial-to-mesenchymal transition (EMT), polykeratins and
proliferative - clusters 12-13-14) and specialised cell clusters: Myo (clusters 7-8), Neuro (clusters 9–10), Ionocytes (cluster 15) and differentiated mTEC
(cluster 11).
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individually harvested at 1, 2, 8, 11, 18 and 22 weeks post-
transplantation (wpt; Fig. 6a and Supplementary Fig. 7a, b). Early
time points were important to confirm stromal cell survival and
re-organisation. At 8 wpt, stroma (TEC and TIC) seeded in
natural scaffolds still showed a cordon-like distribution or
compact epithelial structures by contrast to the unique 3D
thymic epithelial reticulum (Fig. 6a). However, by 11 wpt,
ordered morphogenesis had progressed further, and more mature
thymic structures were consistently detected among scaffolds
seeded with stroma and CD34+ HSC. Among those were
structures very similar to Hassall’s Bodies (HB), an anatomic
trait of human thymus that is much less evident in mouse
(Fig. 6a, b HB indicated by asterisk and Supplementary Fig. 7c).
Immunohistochemistry (IHC) for the epithelial marker E-
Cadherin (ECAD, red) and for the T cell receptor (TCR) (anti-
CD3; green) demonstrated thymic morphogenesis with epithelial
cells forming HB and interacting with CD3+ cells from
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(Vimentin+CK5−) cells, and angiogenesis (as detected by
Endomucin immune-staining) were detected in scaffold trans-
plants (Fig. 6c, lower panel; Supplementary Fig. 7d). In some
experiments VeraVec39 endothelial cells were seeded in addition
to cultivated TEC and TIC since they were reported to favour
faster revascularisation in reconstituted bone marrow (BM)
niches40. However, thymus morphogenesis and T cell develop-
ment occurred independently of the presence of human
endothelial cells at seeding, probably owing to murine vascular-
isation of the scaffold.
To ask whether the reconstituted scaffolds attracted circulating
haematopoietic progenitors, we examined morphogenesis at
18–22 weeks post-transplantation (wpt), and found that thymic
maturation was occurring in most repopulated scaffolds (Fig. 6a)
including those that were not injected with HSC prior to grafting
(Fig. 6b). Moreover, AIRE expression progressively increased
from 11 wpt to 22 wpt (Fig. 6d), and within several areas, with or
without HB, there were scattered CD11c+ dendritic cells (DC),
with HLA-DR expression detected by IHC on DC and by IHC
and FACS on TEC (Fig. 6e and Supplementary Fig. 7e, f).
In order to functionally characterise the implanted scaffolds,
grafts were harvested, dissociated into single cells and analysed by
flow cytometry. CD3+ cells were the prevalent phenotype within
the hCD45+ population within the re-engineered thymic
implants. The high percentage (30–80%) of hCD45+ cells within
each scaffold that were CD3+ indicates that the haematopoietic
progenitors were subjected to an instructive thymic microenvir-
onment provided by cultivated human stromal cells (Fig. 6f),
since BM of the same mice were by contrast primarily
repopulated with CD33+ myeloid and CD19+ B lineage cells
(Supplementary Fig. 8a).
Flow cytometry showed that scaffolds were able to support
thymocyte development (77.5% of all implanted scaffolds), with
SP CD4+ and CD8+ cells expressing TCRαβ (Fig. 6g;). Of note,
the CD4:CD8 ratio for cells maturing in scaffolds favoured CD4+
SP cells (~3:1), a feature of human thymocyte development that is
not seen when circulating human BM-derived progenitors
undergo differentiation within the endogenous thymi of NSG
mice (Supplementary Fig. 8b). Immature SP (ISP) and DP
thymocytes were also present in different proportions within the
scaffolds, demonstrating ongoing thymopoiesis, with consistent
representation of DP cells (Fig. 6g and Supplementary Fig. 8c).
Nonetheless, their reduced presence by comparison to those
reported in human thymi examined directly ex vivo may
reasonably reflect the fact that further optimisation will be
required to establish the precise schedules and kinetics of
differentiation in the native organ. In contrast, no CD3+ cells
were retrieved from scaffolds repopulated with TIC, VeraVec,
HSC CD34+ (without TEC) at 11 wpt or empty scaffolds at 22
wpt (Supplementary Fig. 8d, e).
We sorted hCD45+CD3+ cells from thymus scaffolds and
from the endogenous thymi of NSG mice at 18 wpt, and then
interrogated the cells’ functional potential in vitro. CD3/CD28
Dynabeads® were used to induce the proliferation of sorted cells
for from 12 to 28 days until sufficient cells were obtained for
functional studies. Interestingly, the respective CD4/CD8 ratios of
scaffold-associated or endogenous thymus-associated cells were
sustained upon expansion in culture, indicating that this property
had been differentially “instructed” by human and mouse thymic
stroma. When stimulated in vitro with phorbol myristate acetate
(PMA) and ionomycin (Io), the expanded CD4+ and CD8+ cells
could produce IFNγ and TNFα, whereas IL2 was produced to a
much lesser extent from cells developing in the human scaffolds
than by T cells derived from the NSG thymi, (Fig. 6h). Of note,
thymocytes freshly isolated from human thymus also respond to
PMA-Ionomycin with low IL2 production (Supplementary
Fig. 8f)
Finally, we interrogated the capacity of repopulated scaffolds to
support peripheral T cell reconstitution in an athymic NSG-
Foxn1null (NSG-nude) mouse where the scaffolds were the only
thymic stroma. NSG-nude mice were humanised 4–8 weeks prior
to grafting. Littermate NSG (Hairy) mice were utilised as positive
control for BM and peripheral repopulation (spleen; Supplemen-
tary Fig. 9a, left panels). Upon BM reconstitution no T cells
(hCD3+) were detected in the periphery of these mice when
transplanted with empty scaffolds (Supplementary Fig. 9a, middle
panels). On the contrary, when NSG-nude mice were grafted with
scaffolds previously repopulated in vitro with human thymic
stroma, hCD3+ cells were detected in the periphery (Supple-
mentary Fig. 9a, right panels). Of note, hCD45+CD3+ cells from
the spleens of NSG-nude mice were purified at two time points
(10 wpt and 18 wpt) and analysed for expression of specific genes
supporting TCR-activation including TRBC1/2, TRAV19, NT5E,
CD45RA, TRAC, CD69, PTPN6 (SHP-1), PTPRC, PPIA, CD22
and LTB41–49 (Supplementary Fig. 9b).
Discussion
The data described in this study demonstrate that postnatal
human thymus harbours epithelial (TEC) and interstitial cells
(TIC) that can expand to clinically relevant numbers in vitro,
suitable for contributing to the reconstruction of a human
functional thymus in vivo. This is an important proof-of-
principle that a long-lived phenocopy of a human thymus uti-
lising only postnatal, cultivated cells is achievable.
Our cell sorting strategy for isolating medullary and cortical
subpopulations showed that both mTEC and cTEC expressing
CD49f are enriched for clonogenic TEC with the ability to be
subcultured and to be significantly expanded ex vivo. Interest-
ingly, the expanding mTEC and cTEC mostly lost the signatures
of their respective compartments of origin, seemingly consistent
Fig. 3 Phenotypic analysis of in vitro expanding thymic stromal cells. a Immunofluorescence labelling of thymic epithelial cells in human post-natal
thymus where CK8-18 antibody (yellow), CK5-14 or CD49f (magenta) marked TEC. Tissues contains healthy cells as shown by absence of CASP3 (top mid
panel). Co-staining with CD90 (top left panel), vimentin (VIM, top mid panel) or TE7 (top right panel) in green shows epithelial cells with mesenchymal
features. Bottom panel shows co-expression of VIM (green), CK8-18 (yellow) and transcription factor TP63 (magenta). Arrow and inserts (white) highlight
individual cells with hybrid phenotype. Nuclei are stained with DAPI. Scale bar, 50 μm (n= 4 thymi). b Immunofluorescence labelling of epithelial and
mesenchymal markers on expanding thymic epithelial cells colonies expressing CD90 (left panels), VIM (middle panels) and TE7 (right panels) in green.
Most of TEC in culture co-express cytokeratin CK5-14 (magenta) and CK8-18 (yellow), CD49f (magenta) together with mesenchymal markers. Bottom
panels: left, TEC express proliferation marker MKI67 (green) and right panels: TEC co-express transcription factor TP63 (magenta) with VIM (green).
Nuclei are stained with DAPI (n= 4 independent cultures). Scale bar, 50 μm. c Left panel: phase contrast image of thymic interstitial cells (TIC) expanded
after sorting. Scale bar, 200 μm. Right panel: growth curve shows TIC expansion over several weekly passages (n= 4 independent cultures, data are
presented as mean value ± S.D.). d Immunofluorescence of cultivated TIC demonstrates protein expression for TE7 and vimentin (VIM), as well as
PDGFRβ, NG2 and Smooth Muscle Actin (αSMA), n= 3 independent cultures. Scale bar, 40 μm. e, Representative FACS analysis of expanded TIC for
mesoderm markers PDGFRα (PE), PDGFRβ (PE), n= 5 independent cultures.
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with there being a common progenitor present throughout
thymic tissue5,16,50. Unexpectedly, clonogenic TEC co-expressed
genes and also displayed some behaviour typical of mesenchymal
cells: to our knowledge, this hybrid phenotype is an unique,
cell-intrinsic feature of thymus stroma that is stably maintained
over many passages in culture. A systematic study based on
single-cell clonal analysis, which represents the paradigm of
epithelial stem cells in vitro51,52, will offer the means to further
dissect the complexity and the properties of these thymic
clonogenic cells.
Our combined approach of single-cell transcriptome analysis
with the prospective isolation of medullary and cortical sub-
populations was crucial to identify clusters of cells common to
both medulla and cortex (comTEC) among the highly hetero-
geneous cell types present in the two compartments. The tran-
scriptional profile of the comTEC defined a common medullary
and cortical signature in vivo, including an EMT profile, that were
overtly recapitulated by the clonogenic TEC in vitro. This feature
of the thymus epithelium may be explained by the fact that a 3D






















Fig. 4 Whole-organ thymus perfusion and decellularisation. a Gross appearance of cannulated rat thymi before (upper panels) and after (lower panels)
decellularisation. A 24G cannula is inserted into the carotid artery and used to perfuse the organ with detergent and enzymatic solutions. Asterisks indicate
extra-thymic tissues that allowed connection between thymic tissue and cannula through the large blood vessels (n= 120). Scale bar, 2 mm. b Micro-CT
images of cannulated rat thymus showing extra-thymic tissues, large blood vessels and the 24G cannula entering the artery. Iodine contrast shows clear
demarcation between cortex (C, bright) and medullary (M) areas; blood vessels (asterisks) are represented by very bright areas between and inside the
parenchyma (n= 3). Scale bar, 1.5 mm. c Micro-CT 3D image of whole rat thymus cannulated where iodine contrast shows vasculature tree (segmented in
red, n= 2). Scale bar, 1.2 mm. d Masson’s trichrome stain of a fresh rat thymus lobe staining in red keratins, in blue collagen and in pink cytoplasm.
C cortex, M medulla (n= 3 thymi). Scale bar, 250 μm. e Haematoxylin & Eosin (H&E) stain of a fresh rat thymus. C cortex, M medulla (n= 3 thymi). Scale
bar, 500 μm. fMicro-CT image of cannulated rat thymus showing the whole 2 lobes in 3D. Scale bar, 1.2 mm. gMicro-CT image of a cannulated rat thymus
injected with Microfil® and thresholded to demonstrate perfusion of both thymic lobes. Scale bar, 1.2 mm. h Masson’s trichrome stain of a paraffin section
of a decellularised rat thymus scaffold demonstrating collagen fibres (blue) and absence of keratins, muscle fibres and cell cytoplasm (n= 3 scaffolds).
Scale bar, 250 μm. i H&E of a decellularised thymus scaffold showing intact thymic lobule ECM and preservation of both large and small vasculature wall
(n= 4 scaffolds). Scale bar, 500 μm.
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thymus, but future work should certainly address the molecular
mechanisms that guide this cell-intrinsic property.
Additionally, a distinct, bona fide interstitial cell population
(TIC) could be extensively expanded in vitro and shared several
features with other mesenchymal stromal cells and pericytes.
Those cells were important in guiding TEC during
morphogenesis, both ex vivo and upon transplantation in vivo
since morphogenesis was defective in their absence. Possibly their
role extends beyond supporting TEC development and regen-
eration53, to synergising with TEC in directly regulating T cell
development54,55. Further development of this organ recon-
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systematically the reciprocal and synergistic roles of TEC, TIC,
endothelial and other human stromal cells (e.g. dendritic cells)
during both morphogenesis and thymopoiesis.
Of note, 3D natural ECM were shown to be crucial for thymus
morphogenesis from cultivated cells. To date, it has only been
possible to obtain thymus scaffolds by mechanically shaking or
rotating the organ in a detergent solution13. More recently, it was
demonstrated that native thymic ECM improved re-aggregation
thymic organ cultures in vitro and their T cell output in vivo15.
Both these approaches were based on applying to the mouse
thymus a combination of ionic and non-ionic detergents which
may not be practically applicable to human thymus required for
clinical translation. Instead, the whole-organ perfusion-decel-
lularisation approach that we describe allows preservation of the
fine 3D ECM meshwork that is crucial for both ex vivo mor-
phogenesis and long-term reconstitution in vivo. Moreover,
human cultivated TEC gave rise to Hassall’s Bodies, thus
demonstrating their capacity to maintain key species-specific
characteristics not previously reported for thymic progenitor
differentiation in vivo56,57.
Functional gene products such as AIRE and HLA-DR are also
downregulated in the thymus stroma of human SCID patients
in vivo58, indicating that their expression is dependent on a
complex microenvironment which includes crosstalk between the
stroma and thymocytes. Hence, the conspicuous re-expression of
AIRE and HLA-DR that we observed attests to the degree of
reconstitution achieved in our system.
Crucial to demonstrating the functional competence of TEC
and TIC upon in vitro expansion was their capacity to attract
circulating human HSC, support T cell development and repo-
pulate the periphery of athymic, NSG-nude mice. Species-specific
stroma in an organ such as the thymus is crucial to its own
function; indeed, we consistently achieved a physiologic human
CD4+/CD8+ ratio that was not observed with hybrid mouse-
human in vitro systems of human T cell development14,38.
Importantly, human T cells that developed in vivo within the
human scaffolds were functionally different in their response to
stimulation from those which developed in the mouse thymus,
demonstrating the instructive capacities of the human stroma.
In conclusion, we have used a multidisciplinary approach to
generate an in vivo, long-lasting thymus where both the haema-
topoietic and stroma compartments are of human origin. Such a
system opens the possibility of addressing very many immunolo-
gical questions including the development and functional
maturation of conventional and unconventional human T cells
(e.g. Treg, NK, γδ); positive and negative selection of MHC-I and
II-restricted human T cells; and the roles of additional factors in
the establishment and maintenance of tolerance. Future work and
further optimisation will be needed to estimate the full potential
and limitations of our system in relation to each of these crucial
questions. Notwithstanding, the successful completion of these
steps can allow medically relevant applications such as thymus
transplantation in primary immune deficiencies as athymic
DiGeorge syndrome and Foxn1null (nude) babies; the control of
tolerance in congenital conditions as autoimmune
polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)
patients, and in immunosuppression-free organ transplantations.
Methods
Animals. All animal procedures were in accordance with ethical approval and UK
Home Office Project License (PPL) 70/8904 and PDD3A088A. NOD.Cg-Prkdcscid.
Il2Rγctm1Wjl (NSG) and NOD.Cg-Foxn1em1Dvs.Prkdcscid.Il2Rγctm1Wjl (NSG-Nude,
Stock No: 026263) were obtained from Jackson Laboratory, re-derived and
maintained at The Francis Crick Institute’s biological resource facility or at the
UCL biological unit. Mice were maintained on a 12-h light–dark cycle, ambient
temperature 19/22 °C, and humidity 45/65%. Sprague Dawley rats were kept in the
UCL breeding facility.
Human tissues. Postnatal thymi were donated by patients (age range 3 days to 11
years old) undergoing cardiothoracic surgery at the Great Ormond Street Hospital.
A written informed consent was obtained from the patient parents or legally
authorised representatives under ethical approval (REC No 15/YH/0334 and 07/
Q0508/43-06-MI-13 (B)). Human foetal livers (FL) were provided by the Joint
MRC/Wellcome Trust Human Developmental Biology Resource (HDBR) under
informed ethical consent with Research Tissue Bank ethical approval (REC No 08/
H0712/34+5 and 08/H0906/21+5). Umbilical Cord Blood (CB) was obtained from
normal full-term deliveries after signed informed consent. CB sample collection
was approved by the East London Ethical Committee (REC No 06/Q0604/110) and
in accordance with the Declaration of Helsinki.
Clinical thymus slices preparation and culture. After capsule removal, 8–15 g of
post-natal thymus tissue was processed with Stadie-Riggs microtome (Thomas
Scientific), in order to obtain 1 mm thick slices. Slices were individually mounted
on nitrocellulose filters (Millipore), subsequently placed on Spongostan surgical
sponges (Ferrosan Medical Devices) and bathed in culture medium (F12 (Gibco),
10% Heat-Inactivated Fetal Bovine Serum (Gibco) and 1% Penicillin/Streptomycin
(Sigma)) in 10-cm Petri dishes up to 21 days; culture media was replaced every day.
CD34+ HSC purification and sorting. Mononuclear cells (MNCs) from two up to
five CB collections were pooled and purified by Ficoll-Paque density centrifugation
(GE Healthcare Life Sciences, Buckinghamshire, UK) followed by ammonium
chloride red cell lysis. Density-separated CB MNCs were magnetically sorted for
CD34 positivity via the EasySep Human CD34 Positive Selection kit (Stemcell
Technologies) according to the manufacturer’s instructions; alternatively, they were
sorted by fluorescent activating cell sorting (FACS). Foetal liver (FL) CD34+ were
isolated from human foetal tissue ranging from 12 to 20 weeks post-conception
(wpc). Tissue digestion was performed at 37 °C using an enzymatic solution
(0.1 U/mL Collagenase A (Roche), 0.8 U/mL Dispase II (Roche) and 100 μg/ml
Fig. 5 Functional repopulation of whole-organ thymus scaffolds. a Gross microscopy representative of a thymus scaffold before (left panel), soon after
injection of stromal cells (middle panel) and following 4 days of culture (right panel). Thymic lobes from empty progressively increase density and get
remodelled as shown by shrinking of the scaffold and increase tissue volume (n= 60 repopulated scaffolds). Scale bar, 4 mm. b Immunofluorescence
labelling of thymic epithelial cells (TEC) grown within a decellularised scaffold demonstrating presence of CK5-14+, TP63+ and CD49f+ TEC. Nuclei are
stained with DAPI (n= 4 repopulated scaffolds). Scale bar, 30 μm. c H&E staining shows histology of a scaffold repopulated only with TEC and cultivated
for 5 days (n= 4 repopulated scaffolds). Scale bar, 50 μm. d Haematoxyin & Eosin (H&E) staining of a scaffold repopulated with both expanded clonogenic
TEC and thymic interstitial cells (TIC) and cultivated for 5 days prior to fixation and histological analysis. Stromal cells reorganise along the scaffold with a
pattern similar to the one (e) observed in early (9-week post-conception, wpc) human foetal thymus (n= 4 repopulated scaffolds and n= 2 human foetal
thymi). Scale bar, 100 μm. f Immunofluorescence labelling of TEC seeded together with TIC and grown within a decellularised scaffold demonstrating CK5-
14+ cells localised in the subcapsular region while CK8+ cells prevalently localised in the inner regions; TP63+ TEC were mainly CD49f+. Nuclei are
stained with DAPI (n= 4 repopulated scaffolds). Scale bar, 100 μm. g H&E staining of a scaffold repopulated with TEC, TIC and haematopoietic progenitors
after 7 days of culture (n= 4 repopulated scaffolds). Scale bar, 100 μm. h Representative FACS analysis (n= 6 repopulated scaffold in three independent
experiments) of CD45-positive population isolated from repopulated scaffold seeded with triple negative (TN, CD3−CD4−CD8−) progenitors and co-
cultured for 8 days. The FSC-A, SSC-A plot displays the presence of cells as well as of debris derived from the scaffold ECM during dissociation for release
of haematopoietic cells (top left panel). Viable cells were ~90% of total cells (top mid panel). TN developed within the scaffold gave rise to double positive
(DP) and single positive (SP) CD4 and CD8 expressing cells (top right panel, 5000 cells). Live cells were positive for CD1a and negative for CD33 (bottom
right panel). CD4 and CD8 were positive for CD3 and express TCRαβ (bottom mid and left panel).
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DNase I (Roche) in RPMI, 2% FBS and 1% Penicillin/Streptomycin). Cells were
pelleted and processed for ammonium chloride red cell lysis. FL MNCs were
magnetically sorted for CD34 positivity.
Thymocyte isolation and sorting. Human thymocytes were obtained by
mechanical tissue dissociation of postnatal thymi. Enrichment of triple negative
(TN, CD3−CD4−CD8−) cells was achieved by magnetic sorting using biotinylated
anti-CD3, anti-CD4, anti-CD8a and anti-CD235ab antibodies (BioLegend) and
Magnisort SAV negative beads (Invitrogen). The negative-selected fraction was
processed for FACS purity sorting (CD11c−CD19−CD56−CD3−CD4−CD8− cells;
FACSAria III machine, BD Bioscience; FACSDiva 8.0.1 software).
Isolation and cultivation of thymic stromal cell. We assessed human thymi
obtained from 33 patients ranging in age from 3 days to 11 years who underwent
a
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open-chest cardiac surgery. All thymi, independent of donor age, contained clo-
nogenic TECs generating colonies that could be expanded extensively upon weekly
passage. Thymic tissue fragments were dissociated to single cells by enzymatic
treatment (0.4 mg/mL Collagenase D (Roche), 0.6 mg/mL Dispase II (Roche),
40 μg/mL DNAse I (Roche)) for ~30–45min at 37 °C. Cells were pelleted and re-
suspended for cell counting. Freshly dissociated thymic cells were plated over a layer
of lethally irradiated mouse fibroblast (3T3-J2). Alternatively, thymus single-cell
suspension was depleted of CD45 and CD235ab (red blood) expressing cells by
immunomagnetic separation. The enriched fraction was stained and sorted using
FACSAria III machine (FACSDiva 8.0.1 software) for cortical (EpCAMlowCD205+)
and medullary (EpCAMhighCD205−) thymic epithelial cells (TEC) prior to cell
culture over 3T3-J2 feeders.
Epithelial cells expanded in cFAD medium composed by a mixture of 3:1 of
DMEM-1X (Gibco) and F-12 Nut Mix (Gibco), supplemented with 10% Fetal
Bovine Serum (Sigma), 1% penicillin and streptomycin (100X, Sigma),
Hydrocortisone (0.4 µg/ml, Calbiochem), Cholera Toxin (10−10 M, Sigma),
Triodothyronine (T3) (2 × 10−9 M Sigma) and Insulin (5 µg/ml, Sigma). Human
epithelial growth factor (hEGF, 10 ng/ml, PeproTech) was added after 3 days of
culture and then every other day at each feeding. TEC were plated with a density of
2000–4000 cells/cm2, incubated at 37 °C and 6% CO2 reaching confluence between
5 and 7 days of culture19,50. TEC colony-forming efficiency (CFE) assay was
performed every other passage. Five-hundreds cells were obtained by a serial
dilution and plated over lethally irradiated 3T3-J2 feeders in 60 mm tissue culture
dishes. After 12 days of culture, growing colonies were fixed in 4%
Paraformaldehyde (PFA) and stained with Rhodamine-B (1%, SIGMA-ALDRICH)
for 15 min. Colonies were scored under a dissecting microscope.
Interstitial cells of the thymus (TIC) were derived either by sorting EpCAM−
stroma-enriched thymic population or by explants of human thymus. Fragments of
thymic tissue were placed on 60 mm dishes pre-coated with MatrigelTM (Corning),
diluted 1:100 in Megacell medium (Sigma). Fragment were left to adhere for 30 min
and then gently covered with Megacell medium supplemented with 2.5% FBS HI
(Life Technologies), 1% Penicillin/Streptomycin (Sigma), 1% L-glutamine (Life
Technologies), 1% Non-Essential Aminoacids (Life Technologies), 100 mM beta-
Mercaptoethanol (Life Technologies) and basic-FGF (Sigma). After 7 day of
culture, the cells outgrown from the explants were harvested, cultured at 37 °C in a
6% CO2 and 5% O2 atmosphere and passaged every 3–4 days, when TIC reached
confluence33.
Lymphocyte culture and in vitro stimulation assay. Human CD45+/CD3+
sorted cells were cultured in RPMI 1640 (Gibco), Glutamax (Life Technologies)
with 10% Foetal Bovine Serum (FBS, Life Technologies), 1% Penicillin/Strepto-
mycin (Life Technologies) and supplemented with human recombinant IL2
(50 U/mL, R&D system) and IL-7 (5 ng/mL, Invitrogen) up to 28 days in 96, 48 and
24 wells (Falcon). For expansion, anti-CD3/CD28 beads (Thermofisher) were
added in the proportion of 1:1.
Cytokine production was assessed by Phorbol Myristate Acetate (PMA) and
Ionomycin (Io) stimulation assay: human CD45+/CD3+ sorted T cells and freshly
isolated human thymocytes were incubated in RPMI, supplemented with 20%
Human Serum Heat Inactivated (SIGMA-ALDRICH), Protein Transport Inhibitor
Cocktail (500X, eBioscience), PMA (40 ng/mL, SIGMA-ALDRICH) and Io
(4 μg/mL, SIGMA-ALDRICH) for 6 h at 37 °C. T cells were then washed with
HBSS solution and stained for CD3, CD4 and CD8 (BioLegend), as well as APC-
Cy7 fixable viability dye (Invitrogen), before fixation and permeabilisation with
intracellular staining buffer kit (BioLegend) and intracellular staining with
antibodies anti- IFNγ, anti-TNFα and anti-IL2 (BioLegend). Expanded and
unstimulated T cells were used to set the FACS gates.
Endothelial cells (HuVEC-VeraVec) culture. Human endothelial cells (Angio-
crine, CAT: HVERA101) were cultivated on a layer of 0.1% gelatine (Merck) in
Medium 199 (Gibco) supplemented with 20% Foetal Bovine Serum, FBS (Gibco),
1% Antibiotic/Antimicotic (ThermoFisher), 10 mM HEPES (Gibco), 100 μg/ml
Heparin (SIGMA-ALDRICH) and 50 μg/ml endothelial supplement ECGS
(Millipore).
Flow cytometry analysis. Single-cell suspensions were stained with ad hoc anti-
body mix (Supplementary Table 1) in Hanks Balanced Salt Solution (HBSS, Life
Technologies) supplemented with 2% FBS (Life Technologies) for 30 min on ice.
DAPI (SIGMA-ALDRICH) or Zombie Live-Dead dye (Invitrogen) was used to
discriminate live from dead cells. FACS phenotypic analysis was performed using
Fortessa X-20 machine (BD FACSDiva8.0.1 software) and FlowJoTM software (BD
Bioscience). Gating strategies are detailed in the Supplementary Fig. 10.
RNA isolation and RT-qPCR. Cultured and freshly isolated cells were collected for
gene expression analysis in either BL-Buffer from ReliaPrep™ kit (Promega) or in
Trizol TRI Reagent (SIGMA-ALDRICH) following the manufactures instructions.
Precipitated and dried RNA was re-suspended in nuclease-free water (Qiagen).
RNA concentration was measured using Nanodrop1000 (ThermoScientific)
and RNA integrity (RIN) was evaluated using BioAnalyzer 2100 (Agilent). If
needed, RNA was amplified using Ovation® RNA Amplification System V2
(Nugen) following the manufacturer’s instructions. Alternatively, RNA was con-
verted into cDNA with GoScript™ Reverse Transcriptase kit (Promega) according
to the manufacturer’s protocol. cDNA concentration was adjusted to 10 ng/μl.
Quantitative (q)PCR was performed using PCR master mix (PrecisionPLUS-R -
Primerdesign Ltd) with low-ROX and Taqman qPCR probes (Integrated DNA
Technology, Supplementary Table 2) in MicroAmp Fast Optical 96 well Reaction
Plates (Applied Biosystems) using the QuantStudio 3 Real-Time PCR System
(Applied Biosystems).
Single-cell RNA sequencing – 10X genomics. The cell numbers were confirmed
using an Eve automated cell counter (NanoEnTek). Where possible an appropriate
volume for 10,000 cells was made up to 46.6 μl with nuclease-free water. For lower
cell concentrations 46.6 μl of cell suspension was loaded without further dilution.
Reverse transcription and library construction were carried out following the
Chromium single-cell 3′ reagent v3 protocol (10x Genomics) according to the
manufacturer’s recommendations. Total complementary-DNA synthesis was per-
formed using 12 amplification cycles, with final cDNA yields ranging from ~3 ng/μl
to 15 ng/μl. The 10x Genomics sequencing libraries were constructed as described
and sequenced on an Illumina HiSeq 4000, with read lengths of 28-8-98.
Bioinformatics data analysis of single-cell data. Raw sequencing data were
processed using the CellRanger pipeline (10x Genomics). Count tables were loaded
into R and further processed using the Seurat 3R package59. We removed all cells
with fewer than 200 distinct genes observed or cells with more than 20% (samples
mTEC1, mTEC2) or 30% (samples cTEC1, cTEC2) of unique molecular identifiers
stemming from mitochondrial genes. Principal component analysis was then
performed on significantly variable genes and the first 20 principal components
were selected as input for clustering and UMAP based on manual inspection of a
principal component variance plot (‘PC elbow plot’). Clustering was performed
using the default method from the Seurat package, with the resolution parameter
set to 0.5. Area under the curve (AUC) summary intensity plots were prepared
using the R-package AUCell.
Fig. 6 Repopulated thymus scaffolds mature in vivo and promote functional T cell development. a H&E staining of histological sections of thymic
scaffolds harvested at different time points post-transplant (8, 11, 18 and 22 wpt). Asterisks indicates Hassall’s Bodies (HB); n= 18 scaffolds in 3
independent experiments. Scale bar, 100 μm. b H&E of histological section of a thymic scaffold not seeded with CD34+ HSC at grafting and harvested at 18
wpt; Asterisks indicates Hassall’s Bodies (HB). Scale bar, 100 μm. c Immunofluorescence analysis for CD3, E-Cadherin, CK5, Vimentin (VIM) and mouse
Endomucin (Emcn) at 11 wpt for thymic scaffolds repopulated with stroma and CD34+ HSC; n= 4 scaffolds in two independent experiments. Scale bar,
50 μm. d Immunohistochemistry for AIRE-1 of thymus scaffolds harvested at 11, 18 and 22 wpt demonstrate progressive increase of AIRE-1+ cells; n=
8 scaffolds in three independent experiments. Scale bar, 50 μm. e HLA-DR was detected in cytokeratin-positive medullary (CK5) and cortical (CK8) cells in
repopulated scaffolds by immunofluorescence; n= 18 scaffolds in three independent experiments. Scale bar, 25 μm. f Representative FACS analysis of a
dissociated thymic scaffold at 11 wpt showing presence of CD3+ cells (80% of total human (h) CD45+ population; n= 9 scaffolds). g FACS analysis of
dissociated thymic scaffolds demonstrates both double positive (DP) and single positive (SP) CD4 and CD8 cells. SP CD4 and CD8 cells also expressed
CD3 and TCRαβ, demonstrating the presence of immature single positive (ISP) as well as fully mature thymocytes at both 11 wpt and 18 wpt time points
(n= 9 scaffolds, live cells= 1100–3800). h Representative FACS analysis of sorted and in vitro expanded CD3+ cells. CD3+ cells were sorted either from
repopulated thymus scaffolds or from the endogenous NSG thymus 18 wpt, expanded in vitro prior to FACS analysis that shows presence of CD4+ and
CD8+ SP cells. Expanded CD4+ and CD8+ cells were stimulated by PMA-ionomycin and intracellular cytokine staining performed: CD4+ and CD8+
isolated from endogenous mouse thymus were able to produce IL2, TNFα and IFNγ, while SP CD4 and CD8 cells developed within thymus scaffolds were
able to produce only limited amount of IL2. CD8 SP cells, though in minor number in each scaffold compared to CD4+ were able to produce the highest
level of IFNγ and TNFα; n= 2 independent experiments (live cells from scaffolds= 7000 and from endogenous thymus= 52000).
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Bulk RNA sequencing library preparation and analysis. Total RNA was
extracted from cultured cells using the RNeasy Micro Kit (Qiagen) and RNA total
concentration was measured with a Nanodrop spectrophotometer. Total RNA was
depleted of rRNA with Ribo-Zero, retrotranscribed using Superscript II reverse
transcriptase (Invitrogen) and purified with RNA Clean Beads e e Ampure XP
beads (Beckman Coulter).
Libraries were prepared with the TruSeq Stranded Total RNA Sample
Preparation Kit (Illumina) starting from 100 ng of RNA per sample and sequenced
with the Illumina NovaSeq 6000 machine, paired ends, and a coverage of 35
million reads.
RNA-Seq data were aligned with Salmon (GRCh38) and processed as follows.
DEGs lists generation: analyses were performed with edgeR (v. 3.24.3). Significant
DEGs were selected applying a 0.05 cutoff on FDR and a threshold of 1.5 on logFC.
Genes comparison between different cell types: counts were normalised with the
edgeR’s function cpm() with the argument log=T. Then, data were visualised in a
heatmap generated by the function heatmap.2() (gplots v.3.0.1.2).
NanoString analysis. hCD45+CD3+ cells were sorted from the spleen of two
NSG-nude mice at 10 and 18 wpt (8081 and 1869 sorted events, respectively), lysed
and hybridised to a chimeric antigen receptor-T cell panel for profiling 780 human
genes at 65 °C overnight (NanoString Technologies). Hybridised samples were
processed on an nCounter® prep station and data were collected on an nCounter®
digital analyser (NanoString) following manufacturer’s instructions. Raw data were
imported into nSolver4.0 (NanoString) for data quality checks, background
thresholding and normalisation. The 6 spiked-in RNA Positive Control and the 8
Negative controls present in the panel were used to confirm the quality of the run.
Background level was determined by mean counts and 2× s.d. of negative control
probes. Samples that contained fewer than 50% of probes above background or that
had imaging or positive control linearity flags were excluded from further analysis.
Probes that have raw counts below background in all samples were excluded from
differential expression analysis to avoid false-positive results. Data were normalised
by geometric mean of 10 housekeeping genes present in the CAR-T
Characterisation panel.
Histology. Human thymic tissues and scaffolds samples were fixed (for 2 h to
overnight) in 4% PFA and processed for either cryo- or paraffin-embedding. For
cryo-embedding, fixed tissue was equilibrated in sucrose 25% and embedded in O.
C.T. compound (VWR). Cryosections (thickness, 7 µm) were cut on a Leica
Cryostat 3050. For paraffin-embedding, a Leica PelorisII tissue processor and
Sakura Tissue-Tech embedding station were used. Paraffin section (thickness, 3–5
µm) were produced using ThermoFisher rotary microtome. Cryo- or Paraffin
sections were stained with haematoxylin-eosin using an automatic station (Tissue-
Tek Prisma), Masson’s Trichrome Kit (Leica, Raymond A Lamb, BDH Chemicals)
and Van Gieson Staining Kit (Millipore-Merck).
Immunostaining. Tissue sections or coverslips were fixed in 4% PFA, blocked and
permeabilised simultaneously using a solution of 5% Normal Donkey Serum (NDS,
Jackson Immuno Research) in PBS, containing 0.5% of TritonX (TritonTMX-100,
SIGMA-ALDRICH). Tissue sections or cells were incubated with primary anti-
bodies 5% NDS, 0.01% TritonTMX solution overnight at 4 °C. Secondary anti-
bodies were incubated at room temperature for 45 min. Nuclei were counterstained
with Hoechst 33432 (10−6M) or DAPI present in the FluoroshieldTM Mounting
Medium (Abcam). List of primary and secondary antibodies used are listed in the
Supplementary Table 3.
Imaging. Phase contrast images of cultivated cells were acquired using an Olympus
CK40 inverted microscope and Olympus SC50 camera. Live-imaging of cultured
cells was acquired by scope Zeiss Axiovert 135 with Hamamatsu Orca R2 camera
(objectives ×10 NA 0.25 Plan Neofluar).
For histological images Zeiss Axioplan2 microscope with Zeiss Axiocam HRc
colour camera was used. Gross microscopy of organs was imaged using Zeiss
StREO Discovery.V20 microscope and Zeiss Axiocam506 colour camera. Zeiss
LSM710 inverted confocal microscope and Zen Black software was used to acquire
immunofluorescence images. Confocal images were processed using Fiji and
Improvision Volocity LE software.
Vascular microsurgery, perfusion and decellularisation. Male rats ranging from
150 to 220 g in weight were used as source of thymus organs. The thymus lacks a
common artery to supply blood to the whole organ, therefore it is not possible to
perfuse it by inserting a single cannula in the main blood vessel as for other
organs35. We developed a microsurgical approach to obtain whole-organ thymus
perfusion which has been patented (Patent filing number UK1807788.3). Briefly,
the vessels supplying blood to each lobe, were closed with a silk suture thread (size
6.0, F.S.T.) to seal the thymus in the following order: the right common carotid
artery, the right subclavian artery, the right internal mammary artery, the right
costocervical trunk, the right aortic arch, the left aortic arch, the left costocervical
trunk and the left internal mammary artery. The left carotid artery was left open for
subsequent cannulation and perfusion of the organ. Cannulated thymi were
decellularised by perfusion of detergent-enzymatic treatment (DET). Organs were
perfused with dH2O (18.2 mΩ/cm) for 96 h at 4 °C (0.2 ml/min) using a i150n
peristaltic pump (i Pumps). DET was performed with 4% sodium deoxycholate
(SDC; SIGMA-ALDRICH) at room temperature and 0.1 mg/mL DNase-I (SIGMA-
ALDRICH) in 2.5 mM MgCl2 (SIGMA-ALDRICH). Decellularised rat thymi
(scaffolds) were gamma-irradiated with a dose of 1780 Gy and stored in PBS at 4 °C
for several weeks.
Microfocus compute tomography. Rat thymi were extracted, cannulated and
fixed in paraformaldehyde prior to immersion in potassium triiodide (I2KI) con-
trast in a 1:1 ratio with the formalin solution, which was injected into the cannula,
prior to immersion of the thymus into a falcon tube containing the same solution
(~20 ml volume). I2KI with a total iodine content of 63.25 mg/mL (iodine mass of
2.49 × 10−4 mol/mL) was used. Specimens were immersed in the contrast solution
for 48 h prior to scanning. Immediately prior to micro-CT examination, the spe-
cimens were rinsed in distilled water to remove excess surface iodine and padded
dry using gauze. They were wrapped in Parafilm®M and secured in a low-density
plastic cylinder. Isotropic voxel sizes varied according to the geometric magnifi-
cation achieved (inversely correlated with specimen size) and ranged between 5 and
9 µm. X-ray images were acquired using an XT H 320 microfocus-CT scanner with
a multi-metal target (Nikon Metrology, Tring, UK). A tungsten target was used
with an accelerating voltage of 100 kV and current of 100 microamps. Following
micro-CT examination (duration of ~90 min), the specimens were fixed in 10%
formalin to prevent tissue degradation and aid with the removal of iodine prior to
macroscopic examination. Images were reconstructed using CT Pro 3D (Nikon
Metrology, Tring, UK) and post-processed using VG Studio MAX v 3.0 (Heidel-
berg, Germany).
Scanning electron microscopy. The samples were fixed in 4% formaldehyde/2.5%
glutaraldehyde (SIGMA-ALDRICH) in 0.1 M Phosphate Buffer (PB) pH 7.4 for 5 h
at RT. Samples were then washed in 0.1 M PB, cut in ~5 mm and cryoprotected in
25% sucrose, 10% glycerol in 0.05 M PB overnight. Samples were then fast frozen
and fractured in liquid nitrogen using a stainless-steel probe and then placed back
into the cryoprotectant at RT to thaw. Samples were stained in 1% OsO4/1.5%
potassium ferricyanide, washed in H2O and dehydrated in a graded ethanol series,
critical point dried with CO2 using a Leica EM CPD300 and mounted on alumi-
nium stubs using adhesive carbon tabs. The samples were mounted to present the
fractured surfaces to the beam and coated with a thin layer of platinum using a
Quorum Q150 R S sputter coater. Gross images of the samples were taken prior to
SEM imaging on a Leica M205C stereomicroscope. SEM images were recorded
with a FEI Quanta 250 FEG scanning electron microscope.
DNA quantification. DNA from native rat thymi and decellularised organs was
extracted with the PureLink Genomic DNA MiniKit (Invitrogen) according to the
manufacturer’s instructions. DNA samples were measured spectrophotometrically
(NanoDrop™ 1000, ThermoFisher).
Repopulation and in vitro culture of thymic scaffolds. Cell suspension in cFAD
medium of cultivated TEC and TIC (ratio 5:1) were injected (2–3M cells in 100 μl/
lobe) using Insulin Syringes (Terumo, 29.5 G) into decellularised rat thymi. Stromal
cells used for repopulation of scaffolds were derived from 4 months and 6 months
old donors. Seeded thymic scaffolds were cultured for 5 or 6 days in cFAD medium
and then injected with TN (400,000) ± VeraVec (200,000) cells in 50 μl volume
of co-culture medium (DMEM-1X (Gibco), 10% FBS (SIGMA-ALDRICH), 1%
Penicillin/Streptomycin (100X, SIGMA-ALDRICH), Triodothyronine (T3) (2 ×
10−9 M SIGMA-ALDRICH), Insulin (5 µg/ml, SIGMA-ALDRICH) and Cytokines
(Interleukin-7, 5 ng/mL (Invitrogen), Stem Cell Factor 5 ng/mL (Cell Signalling) and
FLT3-L (5 ng/mL, CellGS)). Scaffolds were reconstituted only with TEC (n= 4),
only TIC (n= 2) or with TEC and TIC (n= 5). Fully reconstituted scaffolds (with
TEC, TIC and TN) were kept in co-culture medium (without cytokines, n= 3) and
cultured up to 14 days in cFAD medium.
Bone marrow reconstitution and subcutaneous transplantation. NSG (8–12-
week-old) mice were sub-lethally irradiated with 3.75 Gy from a 137Caesium source
(IBL 637 Gamma Irradiator). For primary engraftment, purified CD34+ cells (100 K
CB-CD34+ or 200 K FL-CD34+/cells) were injected intravenously per mouse.
Engraftment of human cells in the murine bone marrow was assessed at killing.
Subcutaneous implantation of the scaffold was performed in NSG mice 4–6 weeks
post-CD34+ injection. Mice were anaesthetised with a 5-2% isoflurane oxygen gas
combination for induction and maintenance. Buprenorphine 0.1mg Kg−1 was
administered at the induction for analgesia. Under aseptic conditions, 1–3 midline
incisions (0.4 cm) were performed on the back of the mice and scaffolds were
inserted in lateral pockets40. Mice were culled at different time points ranging from
1 to 22 wpt.
We carried out subcutaneous transplantation in three independent experiments
on a total of 16 NSG mice, 14 of which had been humanised with CB-CD34 cells
and 2 with FL-CD34 cells: all mice showed bone marrow reconstitution. The mice
were implanted with 37 repopulated scaffolds, of which 34 were retrieved.
Specifically, eight mice were implanted with repopulated scaffolds containing TIC,
TEC, VeraVec and CD34+ cells (n= 18); six mice received repopulated scaffolds
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-020-20082-7
14 NATURE COMMUNICATIONS |         (2020) 11:6372 | https://doi.org/10.1038/s41467-020-20082-7 | www.nature.com/naturecommunications
without CD34+ cells (n= 13), other two mice received scaffold without VeraVec
cells (n= 6). In addition, two mice received empty (n= 2) and 2 mice TIC only
scaffolds (n= 6). No significant alterations in the extent of blood vessels correlated
with the absence of endothelial cells in the scaffolds.
The NSG-nude female mice (8–12-week-old) were sub-lethally irradiated with
3.25 Gy and subsequently injected intravenously with purified human CD34+ cells.
NSG-nude mice had a lower rate of humanisation than hairy littermates as
established by bone marrow (BM) engraftment (4 out of 12 mice showed 27-55%
hCD45+ cells against the 50–70% hCD45+ in 5 out 5 hairy littermates). Mice with
no BM reconstitution were excluded from further analysis. BM and spleen were
retrieved from humanised mice (one at 10 wpt and one at 18 wpt) engrafted with
stroma-repopulated scaffolds and processed for flow cytometry analysis or sorting.
Two humanised NSG-nude mice grafted with empty scaffolds showed no
peripheral repopulation (no hCD3+ cells detectable in the spleen) at 18 wpt and
20 wpt.
Scaffold FACS analysis and sorting. Repopulated natural scaffolds were
mechanically and enzymatically dissociated using Collagenase I (2 mg/mL, SIGMA,
C0130), Dispase II (1 U/mL, Roche) and DNAse I (80 μg/mL, Roche) in RPMI
1640 and 2% FBS. At the end of digestion, cell suspension was passed through a cell
strainer (100 μm) and then stained with antibodies for FACS sorting or analysis.
We performed sorting and/or analysis of a total of 16 Scaffolds of which 9 were
repopulated with CD34+ HSC and 7 without CD34+ HSC. Four non-repopulated
controls and two scaffolds with only TIC, CD34+ and VeraVec were harvested at
22 wpt and 11 wpt, respectively. Scaffolds were analysed and no thymocytes were
detected. We found CD4/CD8 SP and DP in 14 repopulated scaffolds: in 7 out of
9 scaffolds repopulated with CD34+ HSC and in 7 out of 7 scaffolds repopulated
without CD34+ HSC.
Statistical analysis. For all the experiments included in this study, three or more
biological replicates were performed; the exact sample size (n) for each experi-
mental group/condition, given as a discrete number. Statistical analysis was per-
formed using two-way ANOVA non-parametric, unless stated otherwise. Plots and
graphs were generated with GraphPad PRISM 8.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
RNA-sequencing data are deposited at ArrayExpress database under accession number
E-MTAB-9641 and scRNA-sequencing at Gene Expression Omnibus (GEO) database
under accession number GSE159745. All datasets generated and/or analysed during the
current study are available from the corresponding author upon reasonable request.
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